All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

This activity will review the latest PK recommendations for Factor VIII and IX replacement and how to use and interpret PK parameters to assess treatment plans.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.


Preventing Errors During Sterile Compounding: Taking the Next Steps

Activity Downloads

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.

NOTE: If you attended the live CE activity titled "Preventing Errors During Sterile Compounding: Taking the Next Steps" that was held on December 5, 2017 during the 52nd ASHP Midyear Clinical Meeting & Exhibition in Orlando, Florida AND received CE credit (i.e. a pharmacist or pharmacy technician CE statement with ACPE Universal Activity Number 0221-9999-17-412-L05-P/T), you are ineligible to also receive CE credit for this home-study activity.

Activity Description

More than 90% of hospitalized patients receive some form of intravenous medications or drug infusion therapy during their stay. Unfortunately, this delivery method is not without risks, and errors involving intravenous medications can result in significant patient harm. ISMP’s presentation will address the multi-factorial risks associated with intravenous medications and the need for adoption of proven technologies and best practices to optimize the safety and reliability of sterile compounding. Speakers will discuss safety strategies for infusion therapy and address specific ways to resolve challenges related to operationalizing technology in a variety of pharmacy settings with differing levels of resources.

Learning Objectives

The target audience for this activity includes pharmacists and pharmacy technicians. Upon completion of this activity, participants will be able to:

  • Describe the evolution of quality and safety in infusion therapy.
  • Identify the most common unsafe practices and at-risk behaviors related to the preparation and administration of sterile medications that are associated with patient harm.
  • Discuss the implementation of infusion-related technologies (IV workflow systems, barcode verification, gravimetric analysis) designed to support safe practices during sterile compounding.
  • List key factors that should be considered when justifying the acquisition of technology to improve the reliability of sterile compounding.


Introduction and Overview
Allen Vaida, PharmD, FASHP
Executive Vice President, ISMP

Infusion Management: Where Are We in Terms of Safety?
Christina Michalek, BS, FASHP
Medication Safety Specialist, ISMP

Advancing Infusion Safety in the Pharmacy
Amanda McCoy, PharmD, RPh
Clinical Pharmacist, St. Elizabeth Healthcare, Edgewood, KY

Gravimetrics and Justifying Use of Technology in Sterile Compounding
Lindsey Amerine, PharmD, MS, BCPS
Assistant Director, Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, NC


It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants any significant financial interest or affiliation with companies that manufacture or market products discussed during their presentation. Allen Vaida, Christina Michalek and Amanda McCoy have no relevant commercial or financial relationships to disclose. Lindsey Amerine disclosed the following financial relationships: Honoraria from BD, Amgen and Taiho Oncology for consulting and participation in advisory boards. Conflicts identified were resolved with a peer review process.

Please note: The opinions expressed in this activity should not be construed as those of the CME/CE provider. The information and views are those of the faculty through clinical practice and knowledge of the professional literature. Portions of this activity may include unlabeled indications. Use of drugs and devices outside of labeling should be considered experimental and participants are advised to consult prescribing information and professional literature.

CE Accreditation

Release Date: 02-15-2018
Expiration Date: 02-15-2020

Pharmacists and Pharmacy Technicians

This CE activity is jointly provided by ProCE, Inc. and the Institute for Safe Medication Practices (ISMP). ProCE, Inc. is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-18-077-H05-P/T has been assigned to this knowledge-based home-study CE activity (initial release date 2-15-18). This activity is approved for 1.5 contact hours (0.15 CEU) in states that recognize ACPE providers. This CE activity is provided at no cost to participants. Statements of completion will be issued online at upon completion of the evaluation and post-test with a score of 70% or higher. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.


This CE activity is jointly provided by ProCE, Inc. and Wild Iris Medical Education, Inc. This activity provides 1.5 contact hours of nurse CE credit.

Wild Iris Medical Education, Inc. is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.


This CE activity is supported by an educational grant from BD.


The material presented in this CE activity does not reflect the views of ProCE, Inc. or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.